CathRx Limited is a fast-growing medical device company based in Sydney, Australia. We harness technology to create responsible, sustainable, and novel electrophysiology solutions to the economic and environmental challenges facing our patients, our physicians and our planet. CathRx' latest generation of catheters, the "Khelix" range, is a full suite of diagnostic catheters which includes the world's first regulatory approved (CE Mark) reposable electrophysiology catheters. Risks associated with the re-use of single-use devices are removed through the Company’s patented modular platform where the patient contacting electrode sheath is disposed of after each use effectively eliminating the risk of cross contamination. CathRx has also designed and patented advanced AF Ablation concepts, including irrigated, multi-electrode, linear lesion technology.
